• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KDM4B:万能的钉子?

KDM4B: A Nail for Every Hammer?

机构信息

Department of Pathology, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

Genes (Basel). 2019 Feb 12;10(2):134. doi: 10.3390/genes10020134.

DOI:10.3390/genes10020134
PMID:30759871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6410163/
Abstract

Epigenetic changes are well-established contributors to cancer progression and normal developmental processes. The reversible modification of histones plays a central role in regulating the nuclear processes of gene transcription, DNA replication, and DNA repair. The KDM4 family of Jumonj domain histone demethylases specifically target di- and tri-methylated lysine 9 on histone H3 (H3K9me3), removing a modification central to defining heterochromatin and gene repression. KDM4 enzymes are generally over-expressed in cancers, making them compelling targets for study and therapeutic inhibition. One of these family members, KDM4B, is especially interesting due to its regulation by multiple cellular stimuli, including DNA damage, steroid hormones, and hypoxia. In this review, we discuss what is known about the regulation of KDM4B in response to the cellular environment, and how this context-dependent expression may be translated into specific biological consequences in cancer and reproductive biology.

摘要

表观遗传变化是癌症进展和正常发育过程的重要贡献者。组蛋白的可逆修饰在调节基因转录、DNA 复制和 DNA 修复的核过程中起着核心作用。Jumonj 结构域组蛋白去甲基酶的 KDM4 家族特异性靶向组蛋白 H3 上的二甲基和三甲基赖氨酸 9(H3K9me3),去除了定义异染色质和基因抑制的关键修饰。KDM4 酶在癌症中通常过度表达,使其成为研究和治疗抑制的有吸引力的靶点。该家族的一个成员 KDM4B 尤其有趣,因为它受到多种细胞刺激的调节,包括 DNA 损伤、类固醇激素和缺氧。在这篇综述中,我们讨论了已知的 KDM4B 对细胞环境的调节,以及这种上下文相关的表达如何转化为癌症和生殖生物学中的特定生物学后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/a5d5477037cb/genes-10-00134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/059c5a207fac/genes-10-00134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/2c892ff1ec3d/genes-10-00134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/a5d5477037cb/genes-10-00134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/059c5a207fac/genes-10-00134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/2c892ff1ec3d/genes-10-00134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1205/6410163/a5d5477037cb/genes-10-00134-g003.jpg

相似文献

1
KDM4B: A Nail for Every Hammer?KDM4B:万能的钉子?
Genes (Basel). 2019 Feb 12;10(2):134. doi: 10.3390/genes10020134.
2
KDM4B: A promising oncology therapeutic target.KDM4B:一种有前景的肿瘤治疗靶标。
Cancer Sci. 2024 Jan;115(1):8-16. doi: 10.1111/cas.16005. Epub 2023 Nov 3.
3
Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.Kdm4b 组蛋白去甲基酶是一种 DNA 损伤反应蛋白,在 γ 射线照射后赋予生存优势。
J Biol Chem. 2013 Jul 19;288(29):21376-21388. doi: 10.1074/jbc.M113.491514. Epub 2013 Jun 6.
4
KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.KDM4/JMJD2 组蛋白去甲基化酶:癌细胞中的表观遗传调节剂。
Cancer Res. 2013 May 15;73(10):2936-42. doi: 10.1158/0008-5472.CAN-12-4300. Epub 2013 May 3.
5
Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.热休克蛋白 90(Hsp90)选择性调节 KDM4B/JMJD2B 组蛋白去甲基酶的稳定性。
J Biol Chem. 2013 May 24;288(21):14681-7. doi: 10.1074/jbc.C113.462770. Epub 2013 Apr 15.
6
Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.组蛋白去甲基化酶 KDM4B 通过表观遗传调控 MYC 稳定性加速胶质母细胞瘤的进展。
Clin Epigenetics. 2023 Dec 13;15(1):192. doi: 10.1186/s13148-023-01608-4.
7
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.用于抗癌药物的KDM4组蛋白去甲基化酶抑制剂:专利综述
Expert Opin Ther Pat. 2015 Feb;25(2):135-44. doi: 10.1517/13543776.2014.991310. Epub 2014 Dec 3.
8
Histone demethylase JMJD2B/KDM4B regulates transcriptional program via distinctive epigenetic targets and protein interactors for the maintenance of trophoblast stem cells.组蛋白去甲基酶 JMJD2B/KDM4B 通过独特的表观遗传靶标和蛋白相互作用因子来调节转录程序,以维持滋养层干细胞。
Sci Rep. 2021 Jan 13;11(1):884. doi: 10.1038/s41598-020-79601-7.
9
KDM4B-mediated reduction of H3K9me3 and H3K36me3 levels improves somatic cell reprogramming into pluripotency.KDM4B 介导的 H3K9me3 和 H3K36me3 水平降低可提高体细胞核重编程为多能性。
Sci Rep. 2017 Aug 8;7(1):7514. doi: 10.1038/s41598-017-06569-2.
10
Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical Defects.KDM4B 杂合变异导致全面发育迟缓及神经解剖缺陷。
Am J Hum Genet. 2020 Dec 3;107(6):1170-1177. doi: 10.1016/j.ajhg.2020.11.001. Epub 2020 Nov 23.

引用本文的文献

1
Chromatin modifiers in neurodevelopment.神经发育中的染色质修饰因子
Front Mol Neurosci. 2025 May 21;18:1551107. doi: 10.3389/fnmol.2025.1551107. eCollection 2025.
2
Paternal Exposure to Methylphenidate Induces Poor-Quality Blastocyst and Epigenetic Changes.父方接触哌甲酯会导致囊胚质量不佳及表观遗传变化。
Mol Reprod Dev. 2025 May;92(5):e70026. doi: 10.1002/mrd.70026.
3
FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature.FBXO22基因缺陷定义了一种与独特表观遗传特征相关的生长受限和多系统异常的多效性综合征。

本文引用的文献

1
Distal-less homeobox 5 promotes the osteo-/dentinogenic differentiation potential of stem cells from apical papilla by activating histone demethylase KDM4B through a positive feedback mechanism.远节同源盒 5 通过激活组蛋白去甲基化酶 KDM4B 的正反馈机制,促进根尖乳头干细胞的成骨/成牙本质分化潜能。
Exp Cell Res. 2019 Jan 1;374(1):221-230. doi: 10.1016/j.yexcr.2018.11.027. Epub 2018 Nov 29.
2
Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications.赖氨酸修饰酶之间的相互作用控制位点特异性DNA扩增。
Cell. 2018 Nov 29;175(6):1716. doi: 10.1016/j.cell.2018.11.018.
3
KDM4B promotes gastric cancer metastasis by regulating miR-125b-mediated activation of Wnt signaling.
Am J Hum Genet. 2025 May 1;112(5):1233-1246. doi: 10.1016/j.ajhg.2025.03.013. Epub 2025 Apr 10.
4
Targeting N-Methyl-lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery.靶向癌症中的N-甲基赖氨酸组蛋白去甲基化酶KDM4:天然产物抑制剂作为表观遗传药物发现的驱动力
ChemMedChem. 2025 Feb 16;20(4):e202400682. doi: 10.1002/cmdc.202400682. Epub 2024 Nov 21.
5
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.组蛋白赖氨酸去甲基化酶抑制剂与PARP1抑制剂奥拉帕尼和顺铂的三联组合对头颈部癌细胞具有增强的细胞毒性作用。
Biomedicines. 2024 Jun 19;12(6):1359. doi: 10.3390/biomedicines12061359.
6
KDM4B mutations in human cancers.KDM4B 突变与人类癌症。
Mutat Res. 2024 Jul-Dec;829:111866. doi: 10.1016/j.mrfmmm.2024.111866. Epub 2024 Jun 11.
7
circBRAF promotes the progression of triple-negative breast cancer through modulating methylation by recruiting KDM4B to histone H3K9me3 and IGF2BP3 to mRNA.环状BRAF通过招募KDM4B至组蛋白H3K9me3以及IGF2BP3至mRNA来调节甲基化,从而促进三阴性乳腺癌的进展。
Am J Cancer Res. 2024 May 15;14(5):2020-2036. doi: 10.62347/OOLG5765. eCollection 2024.
8
Genotype-phenotype correlation study of structural abnormalities in a fetal brain caused by a novel KDM4B variant.结构异常的基因型 - 表型相关性研究在胎儿大脑中引起的一种新型 KDM4B 变体。
Mol Biol Rep. 2024 Jan 25;51(1):188. doi: 10.1007/s11033-023-09092-y.
9
Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.JMJD2B表观遗传调节因子的甲基化对其共激活ETV1和JUN转录因子的能力有不同影响。
Int J Biochem Mol Biol. 2023 Dec 15;14(6):101-115. eCollection 2023.
10
Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.组蛋白去甲基化酶 KDM4B 通过表观遗传调控 MYC 稳定性加速胶质母细胞瘤的进展。
Clin Epigenetics. 2023 Dec 13;15(1):192. doi: 10.1186/s13148-023-01608-4.
KDM4B通过调节miR-125b介导的Wnt信号激活来促进胃癌转移。
J Cell Biochem. 2019 May;120(5):7897-7906. doi: 10.1002/jcb.28065. Epub 2018 Nov 28.
4
Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.组蛋白去甲基化酶 KDM4B 通过激活长散布核元件-1 促进 DNA 损伤。
Cancer Res. 2019 Jan 1;79(1):86-98. doi: 10.1158/0008-5472.CAN-18-1310. Epub 2018 Nov 20.
5
Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.解析 KDM4 组蛋白去甲基化酶的表达及其与慢性淋巴细胞白血病不良细胞遗传学发现的关系。
Med Oncol. 2018 Nov 13;36(1):3. doi: 10.1007/s12032-018-1226-0.
6
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.Fbxo22 介导的 KDM4B 降解决定了选择性雌激素受体调节剂在乳腺癌中的活性。
J Clin Invest. 2018 Dec 3;128(12):5603-5619. doi: 10.1172/JCI121679. Epub 2018 Nov 12.
7
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in -deficient breast cancer.KDM4B 调控的未折叠蛋白反应作为 - 缺陷型乳腺癌的治疗弱点。
J Exp Med. 2018 Nov 5;215(11):2833-2849. doi: 10.1084/jem.20180439. Epub 2018 Sep 28.
8
JMJD2B/KDM4B inactivation in adipose tissues accelerates obesity and systemic metabolic abnormalities.脂肪组织中JMJD2B/KDM4B失活会加速肥胖和全身代谢异常。
Genes Cells. 2018 Sep;23(9):767-777. doi: 10.1111/gtc.12627. Epub 2018 Aug 2.
9
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair.克氏循环缺陷型遗传性癌症综合征的特征是同源重组 DNA 修复缺陷。
Nat Genet. 2018 Aug;50(8):1086-1092. doi: 10.1038/s41588-018-0170-4. Epub 2018 Jul 16.
10
Cancer-associated 2-oxoglutarate analogues modify histone methylation by inhibiting histone lysine demethylases.癌症相关的 2-氧戊二酸类似物通过抑制组蛋白赖氨酸去甲基化酶来修饰组蛋白甲基化。
J Mol Biol. 2018 Sep 14;430(18 Pt B):3081-3092. doi: 10.1016/j.jmb.2018.06.048. Epub 2018 Jul 5.